Biogen Pharmachem Industries Limited (BOM:531752)

BOM:531752 Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	-	-	-	-	24.74	16.23
Other Revenue	33.77	11.98	7.89	2.5	0.07	-
Revenue	33.77	11.98	7.89	2.5	24.81	16.23
Revenue Growth (YoY)	-	51.78%	215.26%	-89.91%	52.90%	-
Cost of Revenue	-	-	-	-	20.15	14.81
Gross Profit	33.77	11.98	7.89	2.5	4.66	1.42
Selling, General & Admin	2.58	1.68	0.84	1.75	0.54	0.14
Other Operating Expenses	13.8	13	3.67	2.72	1.08	1.23
Operating Expenses	16.38	14.68	4.51	4.46	1.62	1.37
Operating Income	17.39	-2.7	3.38	-1.96	3.04	0.05
Other Non Operating Income (Expenses)	0	-	-	-	-	-0
EBT Excluding Unusual Items	17.39	-2.7	3.38	-1.96	3.04	0.05
Gain (Loss) on Sale of Investments	-	-	-	-	-3.12	-16.08
Gain (Loss) on Sale of Assets	-	-	15.92	6.63	-	-
Pretax Income	17.39	-2.7	19.31	4.67	-0.09	-16.03
Income Tax Expense	0.23	0.23	-	0.11	-	-
Net Income	17.16	-2.93	19.31	4.56	-0.09	-16.03
Net Income to Common	17.16	-2.93	19.31	4.56	-0.09	-16.03
Net Income Growth	-	-	323.86%	-	-	-
Shares Outstanding (Basic)	790	653	653	653	653	653
Shares Outstanding (Diluted)	790	653	653	653	653	653
EPS (Basic)	0.02	-0.00	0.03	0.01	-0.00	-0.02
EPS (Diluted)	0.02	-0.00	0.03	0.01	-0.00	-0.02
EPS Growth	-	-	323.90%	-	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	18.79%	8.75%
Operating Margin	51.49%	-22.54%	42.87%	-78.19%	12.24%	0.31%
Profit Margin	50.82%	-24.44%	244.67%	181.98%	-0.35%	-98.80%
EBIT	17.39	-2.7	3.38	-1.96	3.04	0.05
EBIT Margin	51.49%	-22.54%	42.87%	-78.19%	12.24%	0.31%
Effective Tax Rate	1.31%	-	-	2.42%	-	-
Revenue as Reported	33.77	11.98	23.82	9.13	24.81	16.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.